Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!


ACC launches project to track cases against inside counsel

Organization says prosecutors and regulators may be targeting in-house lawyers

Are in-house lawyers becoming the scapegoats for corporate misdeeds?

That’s the question the Association of Corporate Counsel (ACC) seeks to answer. The organization, which last week held its annual convention in Orlando, has launched a project that will document the frequency and likelihood of cases in which prosecutors and regulators target inside counsel when their companies are in trouble. To gather the data, the ACC has asked law firms to relay information about their clients’ experiences.

“The government, regulators, perhaps even opposing counsel, have a target on your back,” Amar Sarwal, the ACC’s chief legal strategist, said during the conference last Monday.

The association’s suspicions aren’t unfounded, as there have been multiple cases recently in which in-house counsel and other executives face tougher penalties for company wrongdoing. One case that particularly rattled in-house lawyers was the prosecution of Lauren Stevens, a vice president and associate general counsel at GlaxoSmithKline who was accused of obstructing a government investigation into possible off-label marketing at the pharmaceutical company. Stevens spoke about her experience at the ACC’s convention. Stevens lauded the judge who oversaw her case, Maryland U.S. District Judge Roger Titus, for dismissing the case and criticizing the prosecution for targeting her for doing her job.

Click here to read about lessons from the Stevens case.

For more advice about how to avoid problems when your company is in trouble, read:

Regulatory: Individual liability for corporate FDCA violations—What you don’t know can hurt you

Inside Experts: Be smart about successor liability

Regulatory: Director liability for proxy statement disclosure

Regulatory: Directors and officers and insider trading

7 risk and compliance threats facing in-house counsel

Ashley Post

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.